IGM Biosciences, Inc.
ANTI-PD-L1 ANTIBODIES

Last updated:

Abstract:

Aspects of the invention include isolated anti-PD-L1 antibodies, as well as compositions containing such antibodies, and methods of using the same in the treatment of diseases or conditions that are mediated by PD-L1 signaling.

Status:
Application
Type:

Utility

Filling date:

10 Feb 2021

Issue date:

3 Jun 2021